In the News

Huntington Health is the first in San Gabriel Valley to Offer Aquablation Therapy, the First and Only Image-Guided, Heat-Free Robotic Therapy for the Treatment of Benign Prostatic Hyperplasia (BPH)

Huntington Health is the first in San Gabriel Valley to Offer Aquablation Therapy, the First and Only Image-Guided, Heat-Free Robotic Therapy for the Treatment of Benign Prostatic Hyperplasia (BPH)
Jun 15 2023

Huntington Health, an affiliate of Cedars-Sinai, announced today that it is the first hospital in San Gabriel Valley to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

Aquablation therapy is performed by the AquaBeam™ Robotic System, the first FDA-cleared, surgical robot utilizing automated tissue resection for the treatment of LUTS due to BPH. Aquablation therapy combines real-time, multi-dimensional imaging, automated robotics, and heat-free waterjet ablation for targeted, controlled, and immediate removal of prostate tissue. Combining both cystoscopic visualization and ultrasound imaging, surgeons can create a personalized treatment plan tailored to each patient’s anatomy. Once the map is complete, the robotically controlled, waterjet ablates the prostate tissue, avoiding critical structures to preserve sexual function and continence. Proven in numerous clinical studies, Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size, or surgeon experience.

“We are proud to be the first hospital in the San Gabriel Valley to offer a solution for men with BPH that provides significant, long-lasting symptom relief with lower risk to their sexual function and continence,” said Armen Dikranian, MD, medical director of robotic surgery, Huntington Health. “Aquablation therapy is the much anticipated next step to furthering our commitment to robotic surgery and men’s health.”

BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal. 1 in 2 men ages 51 to 60 have BPH, and the incidence increases every decade of life.

“BPH is one of the most common conditions affecting men’s health as they age,” said Ramin Khalili, MD, medical director of urology, Huntington Health. “It’s important that men talk to their physician and/or urologist if they are experiencing changes in urination, such as frequency, urgency, retention and incontinence.”

If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones, and incontinence. Current BPH surgical treatments often force men to tradeoff between symptom relief and side effects, limiting patients to choose between either a high degree of symptom relief with high rates of irreversible complications such as incontinence, erectile dysfunction, or ejaculatory dysfunction, or a low degree of symptom relief with low rates of irreversible complications.

For more information about this procedure and other surgical procedures as Huntington, visit: huntingtonhealth.org/surgery

For more information on Aquablation therapy, visit: aquablation.com